KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Gross Margin (2016 - 2025)

Historic Gross Margin for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to 82.52%.

  • Eli Lilly's Gross Margin rose 2800.0% to 82.52% in Q4 2025 from the same period last year, while for Dec 2025 it was 83.04%, marking a year-over-year increase of 17300.0%. This contributed to the annual value of 83.04% for FY2025, which is 17300.0% up from last year.
  • Latest data reveals that Eli Lilly reported Gross Margin of 82.52% as of Q4 2025, which was up 2800.0% from 82.91% recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Gross Margin peaked at 84.27% during Q2 2025, and registered a low of 71.02% during Q2 2021.
  • For the 5-year period, Eli Lilly's Gross Margin averaged around 78.88%, with its median value being 79.65% (2023).
  • Per our database at Business Quant, Eli Lilly's Gross Margin crashed by -68700bps in 2021 and then soared by 69300bps in 2022.
  • Quarter analysis of 5 years shows Eli Lilly's Gross Margin stood at 74.37% in 2021, then increased by 6bps to 78.8% in 2022, then grew by 3bps to 80.89% in 2023, then rose by 2bps to 82.24% in 2024, then rose by 0bps to 82.52% in 2025.
  • Its last three reported values are 82.52% in Q4 2025, 82.91% for Q3 2025, and 84.27% during Q2 2025.